Literature DB >> 27163819

An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia.

Wei Li1, Edgar Huang2.   

Abstract

With the rapidly expanding evidence on brain structural and functional changes in type 2 diabetes mellitus (T2DM) patients, there is an increasing need to update our understanding on how T2DM associates with dementia as well as the underlying pathophysiological mechanisms. A literature search of T2DM and dementia or cognition impairments was carried out in electronic databases Medline, EMBASE, and Google Scholar. In this review, the chosen evidence was limited to human subject studies only, and data on either type 1 diabetes mellitus (T1DM) or non-classified diabetes were excluded. T2DM is a risk factor for both vascular dementia (VaD) and Alzheimer's disease (AD), although AD pathological marker studies have not provided sufficient evidence. T2DM interacts additively or synergistically with many factors, including old age, hypertension, total cholesterol, and APOEɛ4 carrier status for impaired cognition functions seen in patients with T2DM. In addition, comorbid T2DM can worsen the clinical presentations of patients with either AD or VaD. In summary, T2DM increases the risk for AD through different mechanisms for VaD although some mechanisms may overlap. Tau-related neurofibrillary tangles instead of amyloid-β plaques are more likely to be the pathological biomarkers for T2DM-related dementia. Degeneration of neurons in the brain, impaired regional blood supply/metabolism, and genetic predisposition are all involved in T2DM-associated dementia or cognitive impairments.

Entities:  

Keywords:  Alzheimer’s disease; mild cognitive impairment; type 2 diabetes mellitus; vascular dementia

Mesh:

Substances:

Year:  2016        PMID: 27163819     DOI: 10.3233/JAD-160114

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  23 in total

Review 1.  Disturbed sleep and diabetes: A potential nexus of dementia risk.

Authors:  Calliope Holingue; Alexandra Wennberg; Slava Berger; Vsevolod Y Polotsky; Adam P Spira
Journal:  Metabolism       Date:  2018-02-01       Impact factor: 8.694

2.  Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes.

Authors:  Ariela R Orkaby; Kelly Cho; Jean Cormack; David R Gagnon; Jane A Driver
Journal:  Neurology       Date:  2017-09-27       Impact factor: 9.910

3.  Comparison of the contributions of impaired beta cell function and insulin resistance to the development of type 2 diabetes in a Japanese community: the Hisayama Study.

Authors:  Masahito Yoshinari; Yoichiro Hirakawa; Jun Hata; Mayu Higashioka; Takanori Honda; Daigo Yoshida; Naoko Mukai; Udai Nakamura; Takanari Kitazono; Toshiharu Ninomiya
Journal:  Diabetologia       Date:  2021-04-28       Impact factor: 10.122

4.  Acupuncture therapy and cognitive dysfunction in patients with type 2 diabetes: A protocol for systematic review.

Authors:  Ting Pan; Xue Zhou; Xuefeng Li; Heran Wang; Meng Meng; Yiran Han; Xin Qian; Chunhai Chen; Xinhua Chen
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

5.  Observational study of vascular dementia in the Spanish elderly population according to type 2 diabetes status: trends in incidence, characteristics and outcomes (2004-2013).

Authors:  Nuria Muñoz-Rivas; Manuel Méndez-Bailón; José M de Miguel-Yanes; Valentín Hernández-Barrera; Javier de Miguel-Díez; Rodrigo Jimenez-Garcia; Ana López-de-Andrés
Journal:  BMJ Open       Date:  2017-08-04       Impact factor: 2.692

Review 6.  Intracellular Cholesterol Trafficking and Impact in Neurodegeneration.

Authors:  Fabian Arenas; Carmen Garcia-Ruiz; Jose C Fernandez-Checa
Journal:  Front Mol Neurosci       Date:  2017-11-17       Impact factor: 5.639

7.  Effects of a mixed berry beverage on cognitive functions and cardiometabolic risk markers; A randomized cross-over study in healthy older adults.

Authors:  Anne Nilsson; Ilkka Salo; Merichel Plaza; Inger Björck
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

8.  Association of plasma ghrelin levels and ghrelin rs4684677 polymorphism with mild cognitive impairment in type 2 diabetic patients.

Authors:  Rong Huang; Jing Han; Sai Tian; Rongrong Cai; Jie Sun; Yanjue Shen; Shaohua Wang
Journal:  Oncotarget       Date:  2017-02-28

Review 9.  Histones and heart failure in diabetes.

Authors:  Veera Ganesh Yerra; Andrew Advani
Journal:  Cell Mol Life Sci       Date:  2018-06-22       Impact factor: 9.261

10.  Changes in Metabolic Syndrome Status and Risk of Dementia.

Authors:  Ji Eun Lee; Dong Wook Shin; Kyungdo Han; Dahye Kim; Jung Eun Yoo; Jinkook Lee; SangYun Kim; Ki Young Son; Belong Cho; Moon Jong Kim
Journal:  J Clin Med       Date:  2020-01-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.